Your browser doesn't support javascript.
loading
Coast-to-coast spread of SARS-CoV-2 in the United States revealed by genomic epidemiology.
Fauver, Joseph R; Petrone, Mary E; Hodcroft, Emma B; Shioda, Kayoko; Ehrlich, Hanna Y; Watts, Alexander G; Vogels, Chantal B F; Brito, Anderson F; Alpert, Tara; Muyombwe, Anthony; Razeq, Jafar; Downing, Randy; Cheemarla, Nagarjuna R; Wyllie, Anne L; Kalinich, Chaney C; Ott, Isabel; Quick, Joshua; Loman, Nicholas J; Neugebauer, Karla M; Greninger, Alexander L; Jerome, Keith R; Roychoudhury, Pavitra; Xie, Hong; Shrestha, Lasata; Huang, Meei-Li; Pitzer, Virginia E; Iwasaki, Akiko; Omer, Saad B; Khan, Kamran; Bogoch, Isaac I; Martinello, Richard A; Foxman, Ellen F; Landry, Marie L; Neher, Richard A; Ko, Albert I; Grubaugh, Nathan D.
Afiliação
  • Fauver JR; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Petrone ME; These authors contributed equally.
  • Hodcroft EB; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Shioda K; These authors contributed equally.
  • Ehrlich HY; Biozentrum, University of Basel, 4056 Basel, Switzerland.
  • Watts AG; Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Vogels CBF; These authors contributed equally.
  • Brito AF; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Alpert T; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Muyombwe A; BlueDot, Toronto, ON, M5J 1A7, Canada.
  • Razeq J; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Downing R; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Cheemarla NR; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06510, USA.
  • Wyllie AL; Connecticut State Department of Public Health, Hartford, CT, 06510, USA.
  • Kalinich CC; Connecticut State Department of Public Health, Hartford, CT, 06510, USA.
  • Ott I; Connecticut State Department of Public Health, Hartford, CT, 06510, USA.
  • Quick J; Department of Laboratory Medicine, Yale School of Medicine, New Haven, CT, 06510, USA.
  • Loman NJ; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Neugebauer KM; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Greninger AL; Department of Ecology & Evolutionary Biology, Yale University, New Haven, CT, 06510, USA.
  • Jerome KR; Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.
  • Roychoudhury P; Institute of Microbiology and Infection, University of Birmingham, Birmingham B15 2TT, UK.
  • Xie H; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT, 06510, USA.
  • Shrestha L; Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Huang ML; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
  • Pitzer VE; Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Iwasaki A; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
  • Omer SB; Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Khan K; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
  • Bogoch II; Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Martinello RA; Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Foxman EF; Department of Laboratory Medicine, University of Washington, Seattle, WA, 98195, USA.
  • Landry ML; Vaccine & Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, 98109, USA.
  • Neher RA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, 06510, USA.
  • Ko AI; Department of Immunobiology, Yale University, New Haven, CT, 06510, USA.
  • Grubaugh ND; Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.
medRxiv ; 2020 Mar 26.
Article em En | MEDLINE | ID: mdl-32511630
ABSTRACT
Since its emergence and detection in Wuhan, China in late 2019, the novel coronavirus SARS-CoV-2 has spread to nearly every country around the world, resulting in hundreds of thousands of infections to date. The virus was first detected in the Pacific Northwest region of the United States in January, 2020, with subsequent COVID-19 outbreaks detected in all 50 states by early March. To uncover the sources of SARS-CoV-2 introductions and patterns of spread within the U.S., we sequenced nine viral genomes from early reported COVID-19 patients in Connecticut. Our phylogenetic analysis places the majority of these genomes with viruses sequenced from Washington state. By coupling our genomic data with domestic and international travel patterns, we show that early SARS-CoV-2 transmission in Connecticut was likely driven by domestic introductions. Moreover, the risk of domestic importation to Connecticut exceeded that of international importation by mid-March regardless of our estimated impacts of federal travel restrictions. This study provides evidence for widespread, sustained transmission of SARS-CoV-2 within the U.S. and highlights the critical need for local surveillance.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Screening_studies Idioma: En Ano de publicação: 2020 Tipo de documento: Article